Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 141.55 Million USD | 0.0% |
| 2023 | 84.22 Thousand USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 82.54 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| 1992 | - AUD | 0.0% |
| 1991 | - AUD | 0.0% |
| 1990 | - AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 42.11 Thousand USD | 0.0% |
| 2024 FY | 141.55 Million USD | 167965.27% |
| 2024 Q4 | 141.55 Million USD | 0.0% |
| 2023 FY | 84.22 Thousand USD | 0.0% |
| 2023 Q4 | 84.22 Thousand USD | 0.0% |
| 2023 Q2 | 126.33 Thousand USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q2 | 46.78 Thousand USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2020 FY | 82.54 Thousand AUD | 0.0% |
| 2020 Q4 | 82.54 Thousand AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1992 FY | - AUD | 0.0% |
| 1991 FY | - AUD | 0.0% |
| 1990 FY | - AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 2.11 Million AUD | -6597.556% |
| Biome Australia Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 540.72 Thousand AUD | -26078.677% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | 221.03 Thousand AUD | -63941.157% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 14.48 Billion AUD | 99.022% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 509.92 Thousand AUD | -27660.006% |
| Starpharma Holdings Limited | 1.95 Million AUD | -7133.247% |
| Nanollose Limited | - AUD | -Infinity% |
| Memphasys Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 13.89 Thousand AUD | -1018791.91% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | - AUD | -Infinity% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 15.88 Million AUD | -791.065% |
| Dimerix Limited | 69.51 Thousand AUD | -203528.881% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.04 Million AUD | -13471.055% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 51.91 Thousand AUD | -272571.443% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | - AUD | -Infinity% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 1.08 Million AUD | -12894.259% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 19.22 Thousand AUD | -736128.496% |
| Paradigm Biopharmaceuticals Limited | 117.48 Thousand AUD | -120384.35% |
| Recce Pharmaceuticals Ltd | 587.1 Thousand AUD | -24010.62% |
| Avecho Biotechnology Limited | 98.22 Thousand AUD | -144012.653% |
| Actinogen Medical Limited | - AUD | -Infinity% |
| Immuron Limited | 132.94 Thousand AUD | -106379.305% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |